| Source: |
| Type: |
| International Prostate Symptom Score Abbreviation: IPSS, I-PSS Type: Clinical outcome / lower urinary tract symptom severity scale / BPH symptom assessment Function: The International Prostate Symptom Score is a validated patient-reported questionnaire used to quantify lower urinary tract symptoms, particularly in patients with benign prostatic hyperplasia. It evaluates seven urinary symptoms: incomplete emptying, frequency, intermittency, urgency, weak urinary stream, straining, and nocturia. Scoring: The seven symptom questions are each scored from 0 to 5, producing a total symptom score ranging from 0 to 35. Higher scores indicate greater symptom severity. The IPSS also includes a separate quality-of-life/bother question. BPH: ↑ IPSS indicates more severe lower urinary tract symptoms and greater disease burden. Favorable Direction: ↓ IPSS is favorable and indicates improvement in urinary symptoms. A reduction of approximately 3 points is commonly considered a clinically meaningful improvement. Interpretation Note: The IPSS measures symptom severity and treatment response but does not by itself establish that the symptoms are caused by prostate enlargement or bladder outlet obstruction. |
| 8307- | FS, | lign, | Efficacy and safety of a flaxseed hull extract in the symptomatic management of benign prostatic hyperplasia: a parallel, randomized, double-blind, placebo-controlled, pilot study |
| - | Trial, | BPH, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1801 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid